ES438313A1 - 8-thiomethylergolines - Google Patents

8-thiomethylergolines

Info

Publication number
ES438313A1
ES438313A1 ES438313A ES438313A ES438313A1 ES 438313 A1 ES438313 A1 ES 438313A1 ES 438313 A ES438313 A ES 438313A ES 438313 A ES438313 A ES 438313A ES 438313 A1 ES438313 A1 ES 438313A1
Authority
ES
Spain
Prior art keywords
formula
see formula
alq
see
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES438313A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES438313A1 publication Critical patent/ES438313A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A procedure for the preparation of 3-thiomethylergolines of the formula ** (See formula) ** where R is H, CN, (see formula), phenyl or alq; R1 is H, Cl, or Br; alq is C1-C3 alkyl; and the dotted line represents the optional presence of a double bond, or a non-toxic pharmaceutically acceptable acid addition salt thereof, characterized by reacting a compound of the formula ** (See formula) ** where R1 and the dotted line are as defined above; and R2 is a methanesulfonate ester or a p-toluenesulfonate ester, with a nucleophilic reagent of the formula ** (See formula) ** where R3 is CN, (see formula), phenyl, or alq, in an inert solvent at a temperature of 20-100ºC, followed by hydrolysis when R3 is (see formula), and compounds of formula (II) where R is H. are desired. (Machine-translation by Google Translate, not legally binding)
ES438313A 1974-06-06 1975-06-06 8-thiomethylergolines Expired ES438313A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US477136A US3901894A (en) 1974-06-06 1974-06-06 8-thiomethylergolines

Publications (1)

Publication Number Publication Date
ES438313A1 true ES438313A1 (en) 1977-05-16

Family

ID=23894677

Family Applications (1)

Application Number Title Priority Date Filing Date
ES438313A Expired ES438313A1 (en) 1974-06-06 1975-06-06 8-thiomethylergolines

Country Status (27)

Country Link
US (1) US3901894A (en)
JP (1) JPS582946B2 (en)
AR (1) AR210736A1 (en)
AT (1) AT344333B (en)
AU (1) AU507574B2 (en)
BE (1) BE829887A (en)
BG (1) BG24812A3 (en)
CA (1) CA1071623A (en)
CH (1) CH617196A5 (en)
CS (1) CS199591B2 (en)
DD (1) DD120438A5 (en)
DE (1) DE2524575A1 (en)
DK (1) DK144160C (en)
ES (1) ES438313A1 (en)
FR (1) FR2273542A1 (en)
GB (1) GB1505296A (en)
HU (1) HU173590B (en)
IE (1) IE41474B1 (en)
IL (1) IL47424A (en)
NL (1) NL180911C (en)
PH (1) PH10992A (en)
PL (1) PL95738B1 (en)
RO (1) RO77543A (en)
SE (1) SE420095B (en)
SU (1) SU613724A3 (en)
YU (1) YU145575A (en)
ZA (1) ZA753638B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147789A (en) * 1974-03-14 1979-04-03 Sandoz Ltd. 6-Methyl-8-thiomethyl-ergolene derivatives
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
JPS5283894A (en) * 1976-01-01 1977-07-13 Lilly Co Eli 88thiomethyl ergoline
GB1549829A (en) * 1976-05-26 1979-08-08 Farmaceutici Italia 10'-methoxy-1',6'-dimethylergoline-8'-beta-methyl-amino(or thio)-pyrazines
IT1192260B (en) * 1977-07-05 1988-03-31 Simes ERGOLINE-2-THIOETHERS AND THEIR SULPHOXIDES DERIVATIVES
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4180582A (en) * 1978-02-08 1979-12-25 Eli Lilly And Company 6-n-Propyl-8-methoxy-methyl or methylmercaptomethylergolines and related compounds as prolactin inhibitors and to treat Parkinson's syndrome
US4202979A (en) * 1979-01-11 1980-05-13 Eli Lilly And Company 6-Ethyl(or allyl)-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4246265A (en) * 1979-10-01 1981-01-20 Eli Lilly And Company 6-n-Propyl-8α-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity
DE3216870A1 (en) * 1982-05-03 1983-11-03 Schering AG, 1000 Berlin und 4709 Bergkamen PHARMACEUTICAL PREPARATIONS WITH A CYTOSTATIC EFFECT
FR2526797A1 (en) * 1982-05-12 1983-11-18 Roussel Uclaf NOVEL 9-OXALYSERGIC ACID DERIVATIVES, THEIR SALTS, PREPARATION METHOD, MEDICAMENT APPLICATION AND COMPOSITIONS COMPRISING THE SAME
CH649998A5 (en) * 1982-08-09 1985-06-28 Sandoz Ag ERGOL DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND HEALING AGENTS, CONTAINING THESE ERGOL DERIVATIVES AS AN ACTIVE SUBSTANCE.
GB8427536D0 (en) * 1984-10-31 1984-12-05 Lilly Industries Ltd Ergoline derivatives
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
US4801712A (en) * 1985-06-24 1989-01-31 Eli Lilly And Company 2-Alkyl(or phenyl)thio-6-n-alkylergolines are dopamine D-1 antagonists without D-2 agonist activity
FR2589734B1 (en) * 1985-11-13 1988-09-02 Roussel Uclaf USE OF ERGOLIN DERIVATIVES FOR OBTAINING A GERIATRIC MEDICINE
HU196394B (en) * 1986-06-27 1988-11-28 Richter Gedeon Vegyeszet Process for preparing 2-halogenated ergoline derivatives
WO2002100888A1 (en) * 2001-06-08 2002-12-19 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Somatostatin-dopamine chimeric analogs
EP1485382B1 (en) * 2002-03-15 2008-11-19 Antibioticos S.p.A. Process for the synthesis of pergolide
CN104768565B (en) 2012-11-01 2017-04-26 益普生制药股份有限公司 Somatostatin analogs and dimers thereof
TWI523863B (en) 2012-11-01 2016-03-01 艾普森藥品公司 Somatostatin-dopamine chimeric analogs
US20190374534A1 (en) 2018-06-08 2019-12-12 Boehringer Ingelheim Vetmedica Gmbh Liquid pharmaceutical compositions comprising pergolide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507248A (en) * 1967-03-16 1971-05-15 Spofa Vereinigte Pharma Werke Process for the preparation of D-6-methylergolin (I) ylacetic acid
DE1935556A1 (en) * 1969-07-12 1971-01-21 Hoechst Ag Process for the production of lysergol
JPS5012398A (en) * 1973-06-08 1975-02-07

Also Published As

Publication number Publication date
CS199591B2 (en) 1980-07-31
GB1505296A (en) 1978-03-30
ATA427975A (en) 1977-11-15
CA1071623A (en) 1980-02-12
YU145575A (en) 1982-02-28
DD120438A5 (en) 1976-06-12
BG24812A3 (en) 1978-05-12
IL47424A (en) 1979-11-30
IE41474B1 (en) 1980-01-16
RO77543A (en) 1982-02-26
CH617196A5 (en) 1980-05-14
IL47424A0 (en) 1975-08-31
DK144160B (en) 1981-12-28
NL180911C (en) 1987-05-18
DK249975A (en) 1975-12-07
HU173590B (en) 1979-06-28
AU507574B2 (en) 1980-02-21
AR210736A1 (en) 1977-09-15
FR2273542B1 (en) 1978-10-06
NL180911B (en) 1986-12-16
IE41474L (en) 1975-12-06
NL7506584A (en) 1975-12-09
JPS582946B2 (en) 1983-01-19
PL95738B1 (en) 1977-11-30
AU8182775A (en) 1976-12-09
SE7506327L (en) 1975-12-08
PH10992A (en) 1977-10-20
DK144160C (en) 1982-06-07
JPS50160300A (en) 1975-12-25
SU613724A3 (en) 1978-06-30
DE2524575A1 (en) 1975-12-18
US3901894A (en) 1975-08-26
ZA753638B (en) 1977-01-26
FR2273542A1 (en) 1976-01-02
BE829887A (en) 1975-12-05
AT344333B (en) 1978-07-10
SE420095B (en) 1981-09-14

Similar Documents

Publication Publication Date Title
ES438313A1 (en) 8-thiomethylergolines
ES457993A1 (en) Isothiazolo-pyridines
ES397370A1 (en) 4-4-alpha-hydroxybenzyl piperidino 4-fluorobutyrophenone derivative
ES421067A1 (en) Procedure for the preparation of new 2-phenylamine-substitute imidazolines. (Machine-translation by Google Translate, not legally binding)
ES442885A1 (en) D-6-methyl-2,8-disubstituted ergolines
ES423232A1 (en) 2-phenylamino-imidazolines-(2)
ES390163A1 (en) Procedure for the preparation of amino-derivatives of pirazolo (3,4-b) pyridine-5-carboxylic acids. (Machine-translation by Google Translate, not legally binding)
ES427433A1 (en) A procedure for preparing a selected chemical compound of the group consisting of nitroimidazool-ethyl O-thiocarbamate. (Machine-translation by Google Translate, not legally binding)
GB1506021A (en) Process for the preparation of 5-triazolo(3,4-b)-benzothiazoles
ES404744A1 (en) Cephalosporin derivatives
ES403124A1 (en) Procedure for obtaining an antibacterial composition. (Machine-translation by Google Translate, not legally binding)
ES410313A2 (en) 3,4-dihydro-6,7-substituted-2,2,3-lower alkyl-4-oxo-(2h)-quinazolecarboxylic acid derivatives useful as analgesic and tranquilizer agents
ES419739A1 (en) 2-aryl-amino-imidazoline-2 compounds
ES419019A1 (en) Indolo-2,3-c quinolinone derivatives
GB1363758A (en) Process for the production of 1,2,4-oxa-diazoles and novel 1,2,4- oxadiazoles
ES418811A1 (en) 10-piperazinyl-dibenzo-b,f thiepins methods for their preparation and compositions containing them
ES441257A1 (en) Heterocyclic compounds
ES440532A1 (en) Process for the production of 3-hydroxy-1,2,4-triazole derivatives
ES419142A1 (en) 2-2-2-methyl-5-nitro-1-imidazolyl-ethyl-2-thiopseudoureas and related compounds
ES444439A1 (en) Procedure for the obtaining of carbonates of cetooxima. (Machine-translation by Google Translate, not legally binding)
ES406248A1 (en) Procedure for the preparation of 1 - phenyl - 2 - amino - imidazolines - (5) and its salts by addition of acid. (Machine-translation by Google Translate, not legally binding)
ES389687A1 (en) A procedure for preparing derivatives of carbonil-dioximorfinan. (Machine-translation by Google Translate, not legally binding)
ES449960A1 (en) Benzodiazepines
ES394325A1 (en) Procedure for the preparation of anilinic derivatives of nicotinic acid. (Machine-translation by Google Translate, not legally binding)
ES405106A1 (en) Substituted pyrrolidines

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19980202